Posts by Sandra Ansanay-Alex
Trust Valley Days
Trust Valley Day is taking place on 2 December 2025 at International Conference Center Geneva.
Read MoreBracco, Limula and UNIFR Join Forces to Create Efficient Cancer Cell Therapies
Cell and gene therapies are promising, but remain extremely expensive. The pharmaceutical company Bracco Imaging, a leader in medical imaging, Limula, a company specialising in the automation of cell therapies, and Professor Nicola Vannini of the University of Fribourg are joining forces to make them more accessible. This public-private partnership is receiving CHF 688,000 in…
Read MoreVivent Biosignals, global leader in digital crop diagnostics, raises CHF 7 Million
Vivent Biosignals, the Vaud-based pioneer of “wearables for plants”, has announced new investment from Agri Investment Fund (AIF), Horticoop, Pymwymic and Swiss private investors. The funding will accelerate Vivent’s commercial scaling of its breakthrough plant biosignal monitoring technology, which is transforming crop management and sustainable food production. “We are thrilled to welcome Agri Investment Fund…
Read MoreThe Swiss Health Valley Shines with Multiple Innovation Awards
The Swiss Health Valley continues to demonstrate its strength as a European powerhouse in life sciences, medtech, and biotechnology. In recent weeks, several startups and innovators from our ecosystem have been honoured with prestigious awards, highlighting the region’s exceptional dynamism and creativity. MoleSense wins the Swiss Innovation Challenge Before an audience of nearly 4,000 people,…
Read MoreBiofactory Competence Center (BCC): A Swiss Hub for Applied Biotech Innovation
Since its founding in 2015, the Biofactory Competence Center (BCC) in Fribourg is a unique biopharmaceutical training and research institution in Switzerland and part of HEIA-FR, the School of Engineering and Architecture of Fribourg. The center has grown into a pivotal player in the Swiss biotech landscape. Located at the crossroads of applied research, industry…
Read MoreDistalmotion secures $150 Million to expand robotic surgery system in US
The Biopôle-based company (Vaud) developed the DEXTER® Robotic Surgery System, a soft tissue surgical robot that uniquely simplifies operations to make the benefits of wristed robotics accessible in any operating room (OR). This new funding will be used primarily to accelerate US commercial adoption of DEXTER, its soft tissue robotic surgery system, as well as to…
Read MoreWomen Scientists Shaping the Future of Health and Science in the Swiss Health Valley
From neurology to nanotechnology, and from molecular biology to cancer immunology, women scientists across the Swiss Health Valley are driving discovery, innovation, and impact.
Read MoreInSphero acquires DOPPL SA and Sun Bioscience Gri3D Technology
InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology.
Read MoreAutonomyo Raises CHF 1.4 M for its Skywalk Device and Starts a Crowdfunding
Swiss medical technology company Autonomyo launches a CHF 550,000 crowdfunding campaign to supplement the CHF 1.4 Million already raised, in order to put Skywalk, a revolutionary rehabilitation device, on the market. Every two seconds, someone in the world suffers a stroke. Every year, 15 million people are affected, and half of them never fully regain…
Read MorePerivision Gets the Startup Nights Healthtech Award
PeriVision SA, a Swiss medtech and AI spin-off from the University of Bern, with offices at Biopôle, is re-imagining eye testing. The startup won 1st place in the HealthTech Award and 1st place in the Final Public Award at Startup Nights. PeriVision’s eye testing platform, VisionOne, combines commercial VR headsets with advanced AI algorithms to…
Read More